Healthcare Market Research Reports

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 20 Jul 2020  |  North America  |  Frost Radar

    Frost Radar™: US Healthcare Data Interoperability Market, 2020

    Benchmarking Future Growth Potential

    Interoperability has become a critical consideration for all health IT (HIT) applications. All the major healthcare stakeholders across the world acknowledge the need to invest in digital infrastructure capabilities to facilitate cross-continuum patient information exchanges and support evidence-based care, at scale. Regulatory agencies are embraci...

    $4,950.00
  2. 09 Jul 2020  |  North America  |  Frost Radar

    Frost Radar™: Global Critical Care Patient Monitoring Market, 2020

    Benchmarking Future Growth Potential

    The ICU is the most data-intensive part of the hospital, as continuous monitoring of patient health generates a huge volume of crucial data valuable for clinical decision making and future research. With digitalization, it is now easy and efficient to use analytics and connectivity solutions to analyze this data and draw insights for better care de...

    $4,950.00
  3. 02 Jun 2020  |  Global  |  Frost Radar

    Frost Radar™: Artificial Intelligence for Healthcare IT, Global, 2020

    Benchmarking Future Growth Potential

    Frost & Sullivan research has identified the core areas in which artificial intelligence (AI)-enabled healtchcare IT solutions are most relevant for hospitals, physicians, and payers. Hospitals that have so far invested in AI-based financial solutions to automate patient access management, reimbursement eligibility matching, and computer-assisted ...

    $4,950.00
  4. 05 May 2020  |  North America  |  Frost Radar

    FROST RADAR™: Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry, 2020

    Benchmarking Future Growth Potential

    Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

    $4,950.00
  5. 09 Oct 2019  |  North America  |  Frost Radar

    Frost Radar in the US Healthcare Data Analytics Market

    A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines

    US-based providers lose an estimated $260 billion to $270 billion annually due to poor financial risk management and lack of infrastructure to support data-driven business decisions. For every dollar claimed, private and public payers on average offer a reimbursement of 86 cents to providers, resulting in a negative margin of 14% per dollar per pat...

    $4,950.00
  6. 23 Sep 2019  |  North America  |  Frost Radar

    Frost Radar in the Immunoassay and Clinical Chemistry Market

    A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines

    The immunoassay and clinical chemistry market is the highest share contributor for the total in vitro diagnostics (IVD) market. Globally valued at $28.7 billion in 2019, this market segment contributes 37.6% of the total IVD market of $76.3 billion. Within the high-medium to low analyzer segment, there are over 40 companies globally. Of these, 14 c...

    $4,950.00